Pharmaceuticals, Biotechnology and Life Sciences
JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform. The company said…
Lindis Biotech GmbH, a clinical stage biopharmaceutical company, and Pharmanovia, a global pharmaceutical company, announced Thursday that catumaxomab has received marketing authorisation from the European Commission (EC), making the drug the only approved drug therapy for malignant ascites (MA) for patients living with this debilitating condition across Europe.
Axplora, a global leader in API small molecule and ADC manufacturing, has announced a landmark €50 million investment in its Mourenx site in Southwest France, securing its position as a key player in the fight against cardiovascular and metabolic diseases.
Global biotechnology company CSL Behring announced on Friday the four-year results from the pivotal HOPE-B study confirming the long-term durability…
Ananda Pharma (AQSE: ANA), is a UK-based developer of licenced, CBD-based medicinal products, has appointed Andy Rust as a commercial adviser, to provide the company with expert advice on its drug development and commercialisation plans.
hVIVO has signed a contract with Inhalon Biopharma to assess its inhaled IN-002 antiviral candidate (“IN-002”) using the hVIVO Respiratory Syncytial Virus (RSV) Human Challenge Model.
Affluent Medical, a French medtech company at the forefront of developing advanced implantable devices, has reached a key milestone in its mission to improve men’s healthas by successfully completing the pilot phase of its clinical study for the Artus system, an innovative artificial urinary sphincter (AUS) designed to treat stress urinary incontinence in men.
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global…
Brenntag Pharma on Wednesday announced the expansion of the collaboration with Citribel for the distribution of citric acids and citrates.…
Novadip Biosciences, a clinical stage biotechnology company specializing in regenerative medicine, Tuesday said it has completed the 12-month post-surgical visit…